The United States is the only wealthy country without universal health coverage. Every other member of the Organisation for Economic Co-operation and Development — every peer country by income, by democratic governance, by advanced healthcare infrastructure — has found a way to ensure that its population has access to healthcare without the financial barriers that leave tens of millions of Americans uninsured or underinsured. They did not all do this the same way. Universal coverage is an outcome, not a design, and the structural paths that different countries have taken to reach it differ substantially — in who pays, who provides, how prices are set, what role private insurance plays, and what the relationship between government and market looks like in their healthcare systems.
This matters for the American reform debate in a specific way. The peer-country experience is the primary empirical evidence base for evaluating what different structural approaches to healthcare produce — not as controlled experiments, since countries differ across many dimensions, but as existence proofs that universal coverage is achievable through multiple routes, and as data on how those routes perform on cost, quality, access, and administrative efficiency. Dismissing that evidence on the grounds that the United States is different from other countries is legitimate up to a point — the United States is larger, more heterogeneous, and more politically complex than most peer countries — but it does not make the evidence irrelevant. What it makes is caution appropriate about direct policy transplantation, not about the relevance of the evidence.
This article examines how four countries — Canada, Germany, Taiwan, and Australia — achieved universal coverage, what their systems actually look like in operation, what problems they have not solved, and what the American context would make easier or harder about each path. The structural categories these countries represent — provincial single-payer, regulated multi-payer, unified single-payer built from scratch, and mixed public-private — are the same categories examined in What Universal Coverage Would Actually Mean. The full landscape of U.S.-specific reform proposals that draw on this evidence is in The Full Range of Reform Proposals.
Canada: Provincial Single-Payer
Canada’s healthcare system — known domestically as Medicare, a name that predates the American program — is the peer-country model most frequently invoked in American healthcare debate, both as an aspiration and as a cautionary tale. Understanding what it actually is requires setting aside both the idealized and the caricatured versions that appear in American political discourse.
Canada’s system is a single-payer model, but the single payer is not the federal government — it is each of the ten provincial and three territorial governments, which administer their own insurance plans within a national framework established by the Canada Health Act of 1984. The federal government provides transfer payments to provinces conditional on their plans meeting five principles: universality, comprehensiveness, portability, public administration, and accessibility. Beyond those principles, provinces have substantial discretion over how their systems are organized, what they cover beyond the required essential services, and how they pay providers.
The system covers physician services and hospital care universally, with no premiums, no deductibles, and no copayments for covered services. What it does not cover — and this is a significant gap — is prescription drugs, dental care, vision care, and long-term care. These services are covered by a patchwork of provincial programs, employer benefit plans, and out-of-pocket spending. The absence of universal pharmaceutical coverage is a significant equity concern and a persistent policy debate in Canada; proposals for a national pharmacare program have been debated for decades without producing federal legislation, though some provincial programs provide meaningful drug coverage for specific populations.
Physicians in Canada are predominantly private practitioners who bill the provincial insurance plan rather than being employed by the government. Hospitals are predominantly private nonprofits that receive global budgets from provincial plans — annual lump-sum payments to cover operating costs, rather than fee-for-service payments for each admission. The global budget model creates different incentives than fee-for-service: hospitals have an incentive to manage costs within their budget rather than to maximize billable services.
The most frequently cited problem with the Canadian system is wait times — particularly for specialist consultations and elective procedures. Wait times vary substantially by province, by specialty, and by procedure, and Canadian data on wait times is better than the rhetoric on either side of the American debate suggests: wait times for some services are long, wait times for others are comparable to American wait times for people with good insurance, and the variation across provinces means that national averages obscure a wide range of experience. Emergency care and primary care are generally accessible without significant waits; elective specialist care is where the wait time problem is most consistently documented.
The Canadian system’s administrative simplicity is real and substantial. A physician in Ontario bills one payer using one fee schedule. There is no prior authorization for most services, no credentialing with multiple insurers, no billing staff managing multiple payer relationships. The administrative savings relative to the American system are among the most consistently documented findings in comparative health systems research.
What the U.S. context would make harder: The provincial structure of Canadian Medicare — with each province administering its own plan — reflects Canada’s federal structure in ways that translate awkwardly to the United States, where the analogous structure would be state-administered plans under federal standards. The variation in existing state Medicaid programs, the political resistance of states to federal healthcare mandates, and the variation in healthcare market structures across states would all complicate a provincial-equivalent transition. The displacement of employer-sponsored insurance — which covers a much larger share of the American population than it does in Canada — would be a more politically and practically complex transition than the Canadian path required.
What the U.S. context would make easier: The United States already has a large and administratively sophisticated federal payer in Medicare, which covers 65 million people and has decades of operational experience. Extending Medicare’s administrative infrastructure to a larger population is a different challenge from building a single-payer system from scratch.
Germany: Regulated Multi-Payer
Germany’s healthcare system is the oldest universal coverage system in the world — the foundations were laid by Bismarck in 1883 — and it represents a different structural path from single-payer that is worth understanding in its own terms. Germany achieves universal coverage through a regulated multi-payer system of nonprofit insurers called Statutory Health Insurance funds, or Krankenkassen, within a framework that eliminates the coverage gaps and risk selection problems of unregulated private insurance markets.
There are approximately 95 Statutory Health Insurance funds operating in Germany, ranging from large national funds to smaller occupation-based or regional funds. All Germans with income below a threshold — approximately 90 percent of the population — are required to enroll in a Statutory Health Insurance fund. People above the threshold can opt out into private health insurance. Employers and employees each contribute approximately 7.3 percent of income to the fund, with the government providing subsidies for low-income enrollees.
The regulatory framework that makes this multi-payer system function as universal coverage is extensive. All Statutory Health Insurance funds must accept any applicant regardless of health status — there is no medical underwriting. All must offer the same minimum benefit package, defined by federal law. Premiums cannot vary by age, health status, or gender — only by fund, and the variation between funds is modest. A sophisticated risk equalization mechanism — payments between funds — redistributes money from funds with healthier-than-average enrollees to those with sicker-than-average enrollees, eliminating the financial incentive to select healthier members.
The result is that competition among Statutory Health Insurance funds is not competition to avoid sick people — the risk equalization removes that incentive — but competition on service quality, supplemental benefits, and administrative efficiency. Enrollees can switch funds, which creates competitive pressure on fund performance without the risk-selection dynamic that characterizes unregulated insurance markets.
Provider payment in Germany is more complex than in Canada. Physicians are paid through regional associations that receive global budgets from the Statutory Health Insurance funds, then distribute payments to individual physicians. Hospitals are paid through a prospective payment system based on diagnosis-related groups similar to the American Medicare system. Pharmaceutical prices are set through a negotiation process that includes comparative effectiveness assessment — new drugs must demonstrate additional benefit over existing treatments to receive a premium price.
Germany’s system has higher administrative complexity than Canada’s but substantially lower than the United States, because the regulatory standardization of benefit packages, billing codes, and risk equalization reduces the payer-specific administrative burden that American providers face. It also has higher cost-sharing than Canada — modest copayments for physician visits and prescription drugs — but with exemptions for low-income enrollees and caps that prevent catastrophic financial exposure.
The problems the German system has not solved include: the dual system of statutory and private insurance creates some inequity, as higher-income people in private insurance tend to get faster access and more amenities. The long-term care financing system — a separate mandatory long-term care insurance program established in 1995 — provides meaningful but not complete coverage and faces fiscal sustainability pressures as the population ages. And pharmaceutical costs, while lower than in the United States, have been rising faster than other healthcare costs.
What the U.S. context would make harder: The German system’s risk equalization mechanism is technically sophisticated and requires a regulatory infrastructure that does not currently exist in the United States for private insurance. The replacement of the existing employer-sponsored insurance system with a mandatory multi-payer framework with standardized benefits and community rating would require displacing a system that 160 million Americans currently use and that many find acceptable.
What the U.S. context would make easier: The ACA’s insurance marketplaces already incorporate some German-style regulatory elements — guaranteed issue, community rating, standardized benefit tiers, risk adjustment. The distance from the ACA’s regulated marketplaces to a German-style regulated multi-payer system, while significant, is shorter than the distance from the current system to a single-payer system.
Taiwan: Single-Payer Built from Scratch
Taiwan’s National Health Insurance system, implemented in 1995, is among the most instructive examples for the American reform debate because it represents a country that built a universal single-payer system rapidly, in a relatively short transition period, from a fragmented prior system with significant uninsured population. Taiwan’s path demonstrates that universal coverage through a single-payer model is achievable in a compressed timeframe — though the specific political and institutional conditions that made it achievable in Taiwan are worth examining carefully.
Before 1995, Taiwan had multiple overlapping insurance programs covering different populations — labor insurance for workers in certain industries, government employee insurance, farmers’ insurance — and a substantial uninsured population. The transition to a unified National Health Insurance system consolidated these programs into a single national plan covering the entire population, financed through income-based premiums paid by individuals, employers, and the government in defined proportions.
The National Health Insurance Administration — the single payer — contracts with virtually all hospitals and clinics in Taiwan, which remain privately owned and operated. Physicians and hospitals are paid through a global budget system: total payments to providers in each sector are capped at a negotiated global budget, and the payment per service unit adjusts so that total payments stay within the cap. If utilization increases faster than the global budget grows, the per-service payment rate declines. This mechanism contains total system costs while preserving provider autonomy about clinical decisions.
Taiwan’s system has produced strong results on the metrics that matter: near-universal coverage achieved rapidly, significant reduction in the uninsured population, high patient satisfaction, competitive international rankings on quality measures, and per-capita spending substantially below the United States. The administrative simplicity of a single payer is evident in Taiwan’s low administrative overhead.
The problems Taiwan’s system faces include: the global budget mechanism creates financial pressure on providers when utilization growth outpaces budget growth, which can affect provider willingness to participate and the time available per patient. The system has faced periodic fiscal sustainability concerns as costs grow and the population ages. And the speed of the 1995 transition — which was politically achievable partly because Taiwan’s prior insurance programs were already government-administered and the infrastructure transition was less dramatic than it would be in the United States — reflects specific political conditions that are not straightforwardly transferable.
What the U.S. context would make harder: The United States’ private insurance industry is a much larger and more politically powerful actor than Taiwan’s was in 1995. The administrative transition from thousands of private payer billing relationships to a single national payer would be organizationally more complex. And the political coalitions required to enact single-payer in the United States — in a system with multiple veto points and well-organized industry opposition — are more difficult to assemble than what was required in Taiwan’s political system.
What the U.S. context would make easier: The United States already has the technical infrastructure of Medicare as an operating single-payer model at large scale. The conceptual and administrative distance from Medicare as it currently operates to a universal Medicare-style system is shorter than building a national health insurance system from scratch, as Taiwan did.
Australia: Mixed Public-Private
Australia’s healthcare system — Medicare, established in 1984 — occupies a distinctive position among peer-country models because it explicitly combines a universal public system with a private insurance sector that covers a substantial share of the population for services beyond what Medicare covers. It is the peer-country model that most closely resembles the layered public-private structure that American reform proposals have sometimes aimed for.
Australian Medicare provides universal coverage for physician services and public hospital care. All residents can see any Medicare-enrolled physician — which includes nearly all physicians — and receive care in public hospitals with no out-of-pocket cost for covered services. Physicians can bill Medicare directly for the scheduled fee, in which case there is no patient cost; or they can bill above the scheduled fee and charge the patient the difference — a practice called balance billing that produces some cost-sharing for patients who choose private physicians.
Private health insurance — used by approximately 45 percent of Australians — covers private hospital care, which offers choice of physician and accommodation amenities not available in public hospitals, as well as dental, optical, and other services not covered by Medicare. The government subsidizes private health insurance through a rebate and imposes a levy on higher-income people who do not purchase private insurance — mechanisms designed to maintain private insurance uptake and reduce pressure on the public system.
The coexistence of public and private systems in Australia has produced a two-tier dynamic that is a persistent equity concern: people with private insurance access private hospitals with shorter waits and more accommodation choice, while people relying on the public system face longer waits for elective procedures. The public system provides universal access but not uniform access in terms of timeliness and amenities. This is a feature of the Australian system that is acknowledged and debated domestically, not a secret dysfunction.
Pharmaceutical coverage in Australia is provided through the Pharmaceutical Benefits Scheme, a national formulary under which listed medications are available at subsidized prices — a model that has been effective at constraining pharmaceutical costs below American levels. The Pharmaceutical Benefits Advisory Committee evaluates drugs for listing based on clinical evidence and cost-effectiveness — explicit health technology assessment of the kind that does not occur in the United States for most coverage decisions.
What the U.S. context would make harder: The Australian system’s balance billing by physicians — the ability to charge above the scheduled fee — produces cost-sharing that the United States would need to design carefully to avoid replicating the financial toxicity problems of the current system. The private insurance sector’s role in Australia is complementary to the public system rather than competitive with it, a relationship that requires active management to sustain.
What the U.S. context would make easier: The Australian mixed public-private model is conceptually closest to some American public option proposals — a universal public floor with private insurance available above it. The political familiarity of this structure, which preserves private insurance rather than displacing it, may make it more achievable in the American political context than a pure single-payer model.
What the Peer-Country Evidence Supports
Across these four models — and the broader set of peer countries that have achieved universal coverage through various structural paths — several conclusions are supported by the evidence with reasonable confidence.
Universal coverage is achievable through multiple structural routes. Single-payer, regulated multi-payer, and mixed public-private systems have all produced universal or near-universal coverage in countries with advanced economies and democratic political systems. The choice among these routes involves genuine tradeoffs — on administrative complexity, on provider payment disruption, on the role of private insurance, on transition cost and difficulty — but it is not a choice between a viable option and an impossible one.
All peer-country systems cost less than the American system, and the difference is primarily about prices and administrative overhead, not utilization. Countries with single-payer systems have lower administrative costs than countries with regulated multi-payer systems, which have lower administrative costs than the United States. The administrative cost gradient tracks the number of payers and the degree of payment system standardization.
No peer-country system has solved all problems. Wait times, fiscal sustainability, pharmaceutical cost growth, long-term care financing, and workforce distribution are challenges that peer countries face in various forms. Universal coverage is not a sufficient condition for a perfect healthcare system; it is a necessary condition for equitable access to whatever level of care a system provides.
The United States is not uniquely incapable of achieving universal coverage. The barriers are political and institutional, not technical or economic. The peer-country evidence — accumulated across decades, across multiple structural models, across countries at various income levels and with various political systems — establishes clearly that the gap between what the United States pays and what it gets is not an inevitable feature of high-income healthcare. It is the product of choices that can be made differently.
This article was researched and drafted with AI assistance under human review. See our full AI and editorial practices.